Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
IJRM-Iranian Journal of Reproductive Medicine. 2012; 10 (4): 363-372
en Inglés | IMEMR | ID: emr-132389

RESUMEN

Osteoporosis is a chronic disease characterized by a decrease in bone mineral density [BMD] and corruption of the microarchitectural structure of bone tissue. It was investigated whether methylprednisolone had a favorable effect on osteoporotic bone tissue in Oophorectomy induced osteoporotic rats whose endogenous adrenaline levels are suppressed with metyrosine. Bone Mineral Density, number of osteoblast-osteoclast, bone osteocalcin levels and alkaline phosphatase [ALP] measurements were performed. Obtained results were compared with that of alendronate. Oophorectomy induced osteoporosis was exacerbated by methylprednisolone. Alentronate prevented ovariectomised induced osteoporosis, but it couldn't prevent methylprednisolone +ovariectomised induced osteoporosis in rats. Combined treatment with methylprednisolon and metyrosine was the best treatment for preventing osteoporosis but metyrosine alone couldn't prevent osteoporosis in ovariectomised rats


Asunto(s)
Femenino , Animales de Laboratorio , Metiltirosinas , Ratas , Osteoclastos/efectos de los fármacos , Prednisolona , Prednisolona/efectos adversos , Combinación de Medicamentos , Ovariectomía/efectos adversos , Osteoblastos/efectos de los fármacos , Densidad Ósea/efectos de los fármacos , Metilprednisolona/efectos adversos , Metilprednisolona , Osteocalcina/efectos de los fármacos , Fosfatasa Alcalina , Alendronato , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA